Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort

被引：0
|
作者：
Kaiwen Shen
Longdi Yao
Jingyuan Zhu
Ximing Gu
Jie Wang
Wei Qian
Zhijian Zheng
Deyuan Fu
Song Wu
机构：
[1] Traditional Chinese Medicine Hospital of Kunshan,Department of General Surgery
[2] Changxing Hospital of Traditional Chinese Medicine,Department of General Surgery
[3] Nanjing Medical University,Department of General Surgery
[4] The First People’s Hospital of Wenling,Department of Thyroid and Breast Surgery
[5] Northern Jiangsu People’s Hospital,Department of Thyroid and Breast Surgery
[6] Yangzhou University Medical Academy,undefined
[7] Guangling District,undefined
[8] The First People’s Hospital of Wenling,undefined
来源：
BMC Cancer | / 22卷
关键词：
Adjuvant chemotherapy; Breast neoplasms; Small tumor; Prognosis; Molecular subtype; Lymph node–negative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort
    Shen, Kaiwen
    Yao, Longdi
    Zhu, Jingyuan
    Gu, Ximing
    Wang, Jie
    Qian, Wei
    Zheng, Zhijian
    Fu, Deyuan
    Wu, Song
    BMC CANCER, 2022, 22 (01)
  • [2] Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer
    Ren, Yi-Xing
    Hao, Shuang
    Jin, Xi
    Ye, Fu-Gui
    Gong, Yue
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    BREAST, 2019, 43 : 97 - 104
  • [3] The necessity of adjuvant chemotherapy in young patients with T1N0M0 breast cancer: a population-based study
    Chen, Sheng
    Chen, Shujie
    Cao, Wei
    Zhou, Xiaoyun
    Wei, Min
    Wang, Jie
    Yang, Li
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [4] The Impact of Neoadjuvant Chemotherapy on Patients With T1N0M0 Triple-Negative and HER-2 Positive Breast Cancer: A Retrospective Analysis Based on the SEER Database
    Cheng, Han
    Dai, Qichen
    Liu, Gang
    Tong, Xiangyu
    Wang, Yipeng
    CLINICAL BREAST CANCER, 2024, 24 (07) : e593 - e599
  • [5] Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis
    Wu, Chenghui
    Huang, Ou
    Wu, Jiayi
    Shen, Kunwei
    Chen, Xiaosong
    Zhu, Siji
    GLAND SURGERY, 2023, 12 (10) : 1375 - 1386
  • [6] Predicting aggressive outcome in T1N0M0 breast cancer
    P Kronqvist
    T Kuopio
    M Nykänen
    H Helenius
    J Anttinen
    P Klemi
    British Journal of Cancer, 2004, 91 : 277 - 281
  • [7] Predicting aggressive outcome in T1N0M0 breast cancer
    Kronqvist, P
    Kuopio, T
    Nykänen, M
    Helenius, H
    Anttinen, J
    Klemi, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (02) : 277 - 281
  • [8] Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database
    Wu, Junzhao
    Lv, Minhao
    Yuan, Peng
    Ma, Youzhao
    Tian, Peiqi
    Li, Lianfang
    Wang, Chengzheng
    Lu, Zhenduo
    Yan, Min
    Chen, Xiuchun
    Liu, Zhenzhen
    GLAND SURGERY, 2022, 11 (08) : 1341 - +
  • [9] Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
    Li, Xiao-Hui
    Zhao, Chong-Yu
    Zhou, En-Liang
    Lin, Xiao-Jun
    BMC CANCER, 2022, 22 (01)
  • [10] Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
    Xiao-hui Li
    Chong-yu Zhao
    En-liang Zhou
    Xiao-jun Lin
    BMC Cancer, 22
12345